发明名称 QUINOXALINE DERIVATIVE
摘要 <p>Disclosed is a quinoxaline derivative represented by the formula (I) belo w, which has PDE 9 inhibitory activity and is useful as an agent for treatme nt of dysuria or the like, or a salt of such a quinoxaline derivative. In th e formula, R1 and R2 independently represent a hydrogen atom, a halogen atom , an alkyl group, an alkoxy group, an acyl group, an amino group or the like ; R3 represents an alkyl group, an aryl group, a saturated carbocyclic group , a saturated heterocyclic group, an acyl group or the like; R4 represents a hydrogen atom, a hydroxy group, an alkyl group or an amino group; R5 and R8 independently represent a hydrogen atom, a halogen atom, an alkyl group, an alkenyl group, an alkoxy group, a cyano group or a nitro group; R6 and R7 i ndependently represent a hydrogen atom, a halogen atom, an alkyl group, an a lkenyl group, an alkynyl group, an alkoxy group, a cyano group, an amino gro up, a carbocyclic group, a heterocyclic group, COR9 or SO2R9; R9 represents a hydrogen atom, a hydroxy group, an alkyl group, an amino group, a pyrrolid in-1-yl group, a piperidin-1-yl group, a piperazin-1-yl group or the like; X represents S or O; and A1, A2 and A3 independently represent N or C.</SDOAB ></p>
申请公布号 CA2671980(A1) 申请公布日期 2008.06.19
申请号 CA20072671980 申请日期 2007.12.12
申请人 ASKA PHARMACEUTICAL CO., LTD. 发明人 OKADA, MAKOTO;SATO, SHUICHIRO;KOBAYASHI, HIDEO;NAKANO, YOUICHI;SHINBO, ATSUSHI;GOTANDA, KOTARO;KAWADE, KENJI
分类号 C07D487/04;A61K31/4985;A61P3/10;A61P7/02;A61P9/10;A61P9/12;A61P11/16;A61P13/02;A61P13/08;A61P13/10;A61P15/10;A61P25/00;A61P25/28 主分类号 C07D487/04
代理机构 代理人
主权项
地址